Investor Schornstein Alexander
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Schornstein Alexander . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-18 13G/A ASMB / Assembly Biosciences, Inc. 728,113 543,523
2025-08-12 13G MEIP / MEI Pharma, Inc. 2,115,000
2025-08-12 13G ASMB / Assembly Biosciences, Inc. 728,113 728,113
2024-12-23 13G/A ASMB / Assembly Biosciences, Inc. 684,113 728,113
2024-12-23 13G ASMB / Assembly Biosciences, Inc. 684,113 728,113
2024-06-24 13D/A ASMB / Assembly Biosciences, Inc. 7,564,292 684,113
2023-11-22 13D/A ASMB / Assembly Biosciences, Inc. 7,164,292 7,564,292
2023-11-03 13D/A ASMB / Assembly Biosciences, Inc. 7,164,292
2023-10-31 13D ASMB / Assembly Biosciences, Inc.